Can Artificial Intelligence be used to Diagnose Glaucoma?
Dr. Michael Boland, MD, PhD, Site Director, Mass Eye and Ear, Lexington, Medical Director, Practice Innovation for Ophthalmology, Massachusetts Eye and Ear and Associate Professor of Ophthalmology, Harvard Medical School discusses presentations from the 2023 American Academy of Ophthalmology annual meeting regarding AI and glaucoma.
Dr. Boland is a member of the Glaucoma Service at Mass Eye and Ear and the Site Director at Mass Eye and Ear, Lexington. He has completed sub-specialty training in the medical and surgical management of glaucoma and is available for consultations for both glaucoma and cataracts. In addition to his clinical practice, Dr. Boland serves as Medical Director of Practice Innovation for Ophthalmology where he provides expert guidance on technology-based innovations that improve the quality of patient care and increase practice efficiency and safety. He has held national leadership positions related to information systems in ophthalmology and is uniquely qualified to embrace new innovations and accelerate the use of technology, including telemedicine.